Development code · Small Molecule
CVL-751
CVL-751 is a development code for Tavapadon, developed by Cerevel Therapeutics Holdings, Inc..
- Status
- Filed (NDA) for Parkinson's disease
- Mechanism
- D1 receptor Partial agonist
- Developer
- Cerevel Therapeutics Holdings, Inc.
Programs
- Tavapadon for Parkinson's diseaseFiled (NDA)Active
Also known as
- PF-06649751
- tavapadon
- 1643489-24-0